Health

GENEVA, July 4 (Reuters) – The World Health Organization (WHO) said on Saturday it would suspend its trials of the antimalarial drug hydroxychloroquine and the combined HIV drug lopinavir / ritonavir in hospitalized patients with COVID-19 after that failed to reduce mortality. “These interim trial results show that hydroxychloroquine and …

This photograph, taken on July 3, 2020, shows a sign from the World Health Organization (WHO) at its headquarters in Geneva, amid the outbreak of COVID-19, caused by the new coronavirus. FACTORY COFFRINI The World Health Organization announced on Saturday that it discontinued trials of the HIV drug combination lopinavir …

This article is republished here with permission from The Associated Press. This content is shared here because the topic may interest Snopes readers; however, it does not represent the work of Snopes verifiers or editors. WASHINGTON (AP) – Vice President Mike Pence has long portrayed the straight man before Donald …

Six months after a pandemic that has killed more than half a million people, more than 200 scientists around the world are challenging the official view of how the coronavirus is spread. The World Health Organization and the US Centers for Disease Control and Prevention contend that you need to …

The World Health Organization (WHO) announced Saturday that it will suspend its trials of the antimalarial drug hydroxychloroquine and HIV treatment lopinavir / ritonavir in hospitalized patients with the coronavirus after the results showed that the drugs did not reduce rates. of mortality. “These interim trial results show that hydroxychloroquine …